Charles River Laboratories and Medigen Vaccine Biologics Corp Collaborate to Advance New Vaccine Development Programs Through Next Generation Sequencing
Go back to Charles River Laboratories and Medigen Vaccine Biologics Corp Collaborate to Advance New Vaccine Development Programs Through Next Generation Sequencing| CHARLES RIVER LABORATORIE (NYSE: CRL) | Delayed: 288.50 -4.85 (1.65%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $293.35 | 52 Week High | $89.18 | |||
| Open | $288.29 | 52 Week Low | $65.70 | |||
| Day High | $291.69 | P/E | 134.19 | |||
| Day Low | $285.34 | EPS | $2.15 | |||
| Volume | 738,889 | |||||
